Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy

Prostaglandins

Volumn 51, Issue 1, 1996, Pages 19-33

  Harada, Yoshiteru ^a,c   Hatanaka, Ko ^a,c   Kawamura, Michiko ^a,c   Saito, Maki ^a,c   Ogino, Michiko ^a,c   Majima, Masataka ^a,c   Ohno, Takashi ^a,c   Ogino, Keiko ^a,c   Yamamoto, Kei ^a,b   Taketani, Yutaka ^a,b   Yamamoto, Shozo ^a,b   Katori, Makoto ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

Author keywords

nimesulide; NS 398; prostaglandin H synthase 2; rat carrageenin induced pleurisy; SC 58125

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; CARRAGEENAN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXUDATE; GENE EXPRESSION; IMMUNOBLOTTING; INFLAMMATION; INFLAMMATORY INFILTRATE; LEUKOCYTE; MALE; NONHUMAN; PLEURISY; RAT;

EID: 0029919697     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-6980(95)00168-9     Document Type: Article

References (43)

1. Herschman, H.R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 13: 241, 1994.
2. Harada, Y., Hatanaka, K., Saito, M., et al. Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced pleurisy. Biorned. Res. 15: 127, 1994.
3. Katori, M., Harada, Y., Hatanaka, K., et al. Induction of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy and effect of a selective COX-2 inhibitor. Adv. Prostaglandin Thromboxane Leukotriene Res. 23: 345, 1995.
4. Tomlinson, A., Appleton, I., Moore, A.R., et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Brit. J. Pharmacol. 113: 693, 1994.
5. Masferrer, J.L., Zweifel, B.S., Manning, P.T., et al. Selective inhibition of inducible cyclo-oxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91: 3228, 1994.
6. Seibert, K., Zhang, Y., Leahy, K., et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91: 12013, 1994.
7. Vane, J.R., Mitchell, J.A., Appleton, I., et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A. 91: 2046, 1994.
8. Crofford, L.J., Wilder, R.L., Ristimaki, A.P., et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: Effects of interleukin-1β, phorbol ester, and corticosteroids. J. Clin. Invest. 93: 1095, 1994.
9. Harada, Y., Tanaka, K., Uchida, Y., et al. Changes in the levels of prostaglandins and thromboxane and their roles in the accumulation of exudate in rat carrageenin-induced pleurisy. - A profile analysis using gas chromatographymass spectrometry. Prostaglandins 23: 881, 1982.
10. Harada, Y., Tanaka, K., Yamashita, K., Ishibashi, M., Miyazaki, H., and Katori, M. The anti-inflammatory mechanism of MK-447 in rat carrageenin-induced pleurisy. Prostaglandins 26: 79, 1983.
11. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55, 1994.
12. Taniguchi, Y., Ikesue, A., Yokoyama, K., et al. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharmaceutical Sciences, 1: 173, 1995.
13. Ishimura K., Suzuki T., Fukui K., et al. Immunocytochemical localization of prostaglandin endoperoxide synthase in the bovine intestine. Histochem. 99: 485, 1993.
14. Kawamura. M., Harada, Y., and Katori, M. Enhancement of endogenous prostaglandin 12 (prostacyclin) generation in vivo by a phenolic anti-inflammatory agent in the rabbit. Jpn. J. Pharmacol., 57: 113, 1991.
15. O'Banion M.K., Winn V.D., and Young, D.A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxyganase. Proc. Natl. Acad. Sci. U.S.A. 89: 4888, 1992.
16. Kujubu D.A., and Herschman H.R. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/ cyclooxygenase gene. J. Biol. Chem. 267: 7991, 1992.
17. Borgeat, P., Hamberg, M., and Samuelsson, B. Transformation of arachidonic acid and homo-linolenic acid by rabbit polymorphonuclear leukocytes; Monohydroxy acids from novel lipoxygenases. J. Biol. Chem. 251: 7816, 1976.
18. Hammarstrom, S. Leukotrienes. Ann. Rev. Biochem. 52: 355, 1983.
19. William, A.S., Rouzer, C.A., and Chon, Z.A. Leukotriene C release by macrophages. Federation Proc. 42: 129, 1983.
20. 2q, and thromboxane in response to late complement components. J. Immunol. 133: 2145, 1984.
21. Utsunomiya I., Nagai S., and Oh-ishi, S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J. Immunol. 147: 1803, 1991.
22. Utsunomiya, I., Nagai, S., and Oh-ishi, S. Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy. Europ. J. Pharmacol. 252: 213, 1994.
23. Yonemoto, K. Complement activation and leukocyte migration in rat carrageenin-induced pleurisy. Jpn. J. Inflammation 3: 51, 1983. (in Japanese with an English abstract)
24. Majima, M., Sunahara, N., Harada, Y., and Katori, M. Detection of the degradation products of bradykinin by enzyme immunoassay as markers for the release of kinin in vivo. Biochemical Pharmacol. 45: 559, 1993.
25. 4 in the exudate of rat carrageenin-induced pleurisy. Prostaglandins 26: 493, 1983.
26. Williams, T.J., and Morley, J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246: 215, 1973.
27. Williams, T.J., and Peck, M.J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270: 530, 1977.
28. 2 and arachidonic acid in rabbit skin. Prostaglandins 10: 747, 1975.
29. 2. Arthritis Rheumatism 37: 653, 1994.
30. 2 increase during carrageenin and zymosan-induced pleurisy in rat. Europ. J. Pharmacol. 248: 27, 1993.
31. Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flower, R.J., and Vane, J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90: 11693, 1994.
32. Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S., and Otomo, S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45: 753, 1993.
33. Tofanetti, O., Casciarri, I., Cipolla, P.V., Cazzulani, P., and Omini, C. Effect of nimesulide on cyclo-oxygenase activity in rat gastric mucosa and inflammatory exudate. Med. Sci. Res. 17: 745, 1989.
34. 2 in inflammatory processes. Nature 265: 170, 1977.
35. Meade, E., Smith, W.L., and DeWitt, D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J. Biol. Chem., 268: 6610, 1993.
36. Reddy, ST., and Herschman, H.R. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 269: 15473, 1994.
37. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232, 1971.
38. Smith, J.B., and Willis, A.L. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 231: 235, 1971.
39. Ferreira, S.H., Moncada, S., and Vane, J.R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature 231: 237, 1971.
40. DeWitt D.L., Meade E.A., and Smith W.L. PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal anti-inflammatory drugs. Amer. J. Med. 95 (suppl 2A): 40S, 1993.
41. Vane, J.R. Towards a better aspirin. Nature 367: 215, 1994.
42. Futaki, N., Yoshikawa, K., Hamasaka, Y., et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. General Pharmacol. 24: 105, 1993.
43. Swingle, K.F., and Moore, G.G.I. Preclinical pharmacological studies with nimesulide. Drugs Exp. Clin. Res. 10: 587, 1984.